ulipristal acetate has been researched along with leuprolide in 8 studies
| Studies (ulipristal acetate) | Trials (ulipristal acetate) | Recent Studies (post-2010) (ulipristal acetate) | Studies (leuprolide) | Trials (leuprolide) | Recent Studies (post-2010) (leuprolide) |
|---|---|---|---|---|---|
| 376 | 41 | 347 | 3,082 | 777 | 772 |
| Protein | Taxonomy | ulipristal acetate (IC50) | leuprolide (IC50) |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | Homo sapiens (human) | 0.0005 | |
| Gonadotropin-releasing hormone receptor | Rattus norvegicus (Norway rat) | 0.0006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baró, F; Bestel, E; Bouchard, P; Donnez, J; Lemieszczuk, B; Loumaye, E; Nouri, K; Osterloh, I; Selvaggi, L; Sodowski, K; Terrill, P; Tomaszewski, J; Vázquez, F | 1 |
| Stewart, EA | 1 |
| Cha, DH; Kim, JY; Kim, ML; Park, JE; Seong, SJ; Shim, JY; Yun, BS | 1 |
| Postma, MJ; van Asselt, AD; Zakiyah, N | 1 |
| Chow, TL; Murji, A; Sobel, ML; Whitaker, L | 1 |
| Allaire, C; Laberge, PY; Leyland, N; Murji, A; Singh, SS; Vilos, GA | 1 |
| De Milliano, I; Frijlingh, M; Hehenkamp, WJK; Huirne, JAF | 1 |
| Nakano, Y; Osuga, Y; Takanashi, M; Yamauchi, Y | 1 |
1 review(s) available for ulipristal acetate and leuprolide
| Article | Year |
|---|---|
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Topics: Amenorrhea; Antineoplastic Agents, Hormonal; Estrenes; Female; Humans; Leiomyoma; Leuprolide; Menstruation; Mifepristone; Norpregnadienes; Oximes; Pelvic Pain; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2017 |
2 trial(s) available for ulipristal acetate and leuprolide
| Article | Year |
|---|---|
Ulipristal acetate versus leuprolide acetate for uterine fibroids.
Topics: Administration, Oral; Adult; Double-Blind Method; Endometrium; Female; Humans; Injections, Intramuscular; Intention to Treat Analysis; Leiomyoma; Leuprolide; Menorrhagia; Middle Aged; Norpregnadienes; Uterine Neoplasms; Young Adult | 2012 |
Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial.
Topics: Adult; Amenorrhea; Double-Blind Method; Female; Humans; Japan; Leiomyoma; Leuprolide; Menorrhagia; Middle Aged; Norpregnadienes; Time Factors; Treatment Outcome; Uterine Neoplasms | 2021 |
5 other study(ies) available for ulipristal acetate and leuprolide
| Article | Year |
|---|---|
Uterine fibroids and evidence-based medicine--not an oxymoron.
Topics: Female; Humans; Leiomyoma; Leuprolide; Menorrhagia; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms | 2012 |
Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Topics: Adult; Antineoplastic Agents, Hormonal; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Caspase 3; Cell Proliferation; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Leuprolide; Middle Aged; Myometrium; Neoplasm Proteins; Norpregnadienes; Proliferating Cell Nuclear Antigen; Receptor, Platelet-Derived Growth Factor alpha; Receptors, LHRH; Receptors, Progesterone; Uterine Neoplasms | 2015 |
Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis.
Topics: Adolescent; Adult; Budgets; Cost Control; Double-Blind Method; Female; Health Care Costs; Humans; Leiomyoma; Leuprolide; Middle Aged; Netherlands; Norpregnadienes; Preoperative Care; Young Adult | 2017 |
Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Topics: Anemia; Antineoplastic Agents, Hormonal; Contraceptive Agents, Hormonal; Female; Gonadotropin-Releasing Hormone; Hematinics; Humans; Iron Compounds; Leiomyoma; Leuprolide; Liver Function Tests; Menorrhagia; Norpregnadienes; Uterine Neoplasms | 2019 |
Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.
Topics: Adult; Antineoplastic Agents, Hormonal; Female; Humans; Leiomyoma; Leuprolide; Neovascularization, Pathologic; Netherlands; Norpregnadienes; Pilot Projects; Premenopause; Treatment Outcome; Tumor Burden; Uterine Neoplasms | 2020 |